Print

Oculus Innovative Sciences, Inc. (OCLS) Reports Revenues Of $4.1 Million For Second Quarter Of Fiscal 2014, Meeting Guidance Of Greater Than $3.6 Million  
11/20/2013 8:48:02 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., Nov. 19, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced financial results for the second quarter of fiscal year 2014, ended September 30, 2013. Total revenues were $4.1 million for the second quarter, down $437,000 as compared to $4.5 million for the same period in the prior year.

Help employers find you! Check out all the jobs and post your resume.

//-->